跳至主要内容
临床试验/CTRI/2022/03/041321
CTRI/2022/03/041321尚未招募2 期

Study of Triphaladi Churnavati In Avegawastha Of Tamakshwas (Bronchial Asthma)

Dr Chinmayi Raut1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年3月31日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
REDUCTION IN SYMPTOMS LIKE BREATHLESSNESS, DIFFICULT TO EXPECTORATE, LIFE THREATING SEVERE BREATHING, CHEST TIGHTNESS IN AVEGAWASTHA OF TAMAKSHWAS.

研究概览

简要总结

TRIPHALADI CHURNAVATI USE IN TAMAKSHWAS PATIENT 30 PATIENTS TAKEN FOR STUDY 1.5 GM BEFORE LUNCH AND DINNER FOR 28 DAYS. FOLLOW UP 0N 7,14,21, 28 DAYS.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • •Patients having signs and symptoms of Avegawastha of Tamakshwas explained in Ayurvedic texts.
  • •Patients of age group 18 years to 70 years.
  • •Patients having signs and symptoms of Bronchial Asthma explained in Modern text.

排除标准

  • •Patients having age less than 18 years and age beyond 70 years.
  • •Patients having complications like haemoptysis, cardiac diseases like Chronic Cardiac Failure, Ischemic Heart disease, Atrial flutter, Atrial fibrillation.
  • •SPO2 less than 90%.
  • •Patients suffering from diseases like Tuberculosis, Malignancy of any part of body, HIV.

结局指标

主要结局

REDUCTION IN SYMPTOMS LIKE BREATHLESSNESS, DIFFICULT TO EXPECTORATE, LIFE THREATING SEVERE BREATHING, CHEST TIGHTNESS IN AVEGAWASTHA OF TAMAKSHWAS.

时间窗: 28 DAYS

次要结局

  • REDUCTION OF SYMPTOMS LIKE WHEEZING SOUND EXAMINED BY AUSCULTATION OF THE LUNGS BY STHETHOSCOPE, DISTURBED SLEEP IN AVEGAWASTHA OF TAMAKSHAWAS.(28 DAYS)

研究者

发起方
Dr Chinmayi Raut
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验